Stay Updated
Press Releases
WASHINGTON, D.C. — In response to President Trump’s new executive order on prescription drug prices, Merith Basey, Executive Director of Patients For Affordable Drugs, issued the following statement: “This executive order (EO) signals that the Administration recognizes the urgency of tackling high drug prices, in line with what the majority of Americans are demanding. The first round […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs (P4AD) has launched a new TV ad set to air nationally on Fox & Friends today. The ad encourages President Donald Trump to continue protecting Medicare’s ability to negotiate lower drug prices – a policy his Administration has defended in court and one that will save patients and taxpayers […]
Press Releases
RELEASE: All 12 Drug Manufacturers Agree To Participate In Second Round Of Medicare Negotiations
Patients For Affordable Drugs Welcomes Key Milestone While Holding Drug Companies Accountable For Ongoing Legal Attacks WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) announced Friday that all 12 manufacturers of the 15 drugs selected for the second round of the Medicare negotiation program voluntarily agreed to participate. While this is another critical step […]
Press Releases
WASHINGTON, D.C. — Today, Patients For Affordable Drugs (P4AD) filed an amicus brief in the U.S. Court of Appeals for the Third Circuit, defending Medicare’s ability to negotiate lower drug prices against a lawsuit brought by pharmaceutical giant Novartis. The lawsuit is part of a broader industry-wide legal assault aimed at dismantling the 2022 prescription drug law’s historic […]
Press Releases
WASHINGTON, D.C. — Following a narrow Senate vote, Robert F. Kennedy Jr., was confirmed today as Secretary of the Department of Health and Human Services (HHS). P4AD Executive Director, Merith Basey, released the following statement: “Secretary Kennedy has a critical opportunity – and responsibility – to build on existing measures to rein in Big Pharma’s price-gouging and lower drug […]
Press Releases
RELEASE: New Report Exposes PhRMA’s Misinformation Campaign To Undermine 2022 Prescription Drug Law
WASHINGTON, D.C. — A new report from Patients For Affordable Drugs reveals that the Pharmaceutical Research and Manufacturers of America (PhRMA) and its allies have spent heavily on advertisements – based on misleading and at times blatantly false claims – designed to undermine the 2022 prescription drug law – a law that is already lowering drug prices and […]
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs welcomes the Centers for Medicare & Medicaid Services (CMS) statement today reaffirming the continuation of Medicare drug price negotiation. P4AD Founder and President, David Mitchell, released the following statement in response: “We are very pleased to see the Medicare prescription drug program move forward under the Trump Administration. […]
Press Releases
P4AD Pushes Back On Pharmaceutical Company Claims, Highlights The Drug Industry’s Decades-Long Prohibition On Medicare’s Ability To Negotiate Lower Drug Prices, And Amplifies The Experiences Of Patients WASHINGTON, D.C. — Patients For Affordable Drugs filed a 29-page amicus brief today in the U.S. Court of Appeals in the Second Circuit, defending the Medicare negotiation program […]